| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |